Skip to main content
. Author manuscript; available in PMC: 2015 Dec 15.
Published in final edited form as: Cancer Res. 2014 Oct 27;74(24):7217–7228. doi: 10.1158/0008-5472.CAN-14-0505

Fig. 6. RTK activation in human lung SCC tissues harboring DDR2 mutations.

Fig. 6

A: DDR2 missense mutations in primary lung SCC samples. Mutational status of H2286 and HCC366 cells are also indicated. TM, transmembrane. B: Whole cell extracts were prepared from 4 tumor samples or the 2 cell lines with DDR2 mutations and then subjected to Western blotting for phospho- and total RTK antibodies.